tiprankstipranks
Blurbs

RBC Capital Reaffirms Their Buy Rating on DuPont de Nemours (DD)

In a report issued on March 24, Arun Viswanathan from RBC Capital maintained a Buy rating on DuPont de Nemours (DDResearch Report), with a price target of $100.00. The company’s shares closed last Friday at $77.09.

According to TipRanks.com, Viswanathan is a 5-star analyst with an average return of 8.7% and a 62.0% success rate. Viswanathan covers the Basic Materials sector, focusing on stocks such as Sherwin-Williams Company, Axalta Coating Systems, and Berry Global Group.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for DuPont de Nemours with a $97.09 average price target, implying a 26.8% upside from current levels. In a report issued on March 18, Deutsche Bank also maintained a Buy rating on the stock with a $90.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on DuPont de Nemours’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $4.27 billion and net profit of $204 million. In comparison, last year the company earned revenue of $3.75 billion and had a net profit of $222 million.

Based on the recent corporate insider activity of 102 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DD in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Delaware-based DuPont de Nemours, Inc., which is commonly known as DuPont, is a multi-industry specialty solutions company and provides specialty materials, chemicals, and agricultural products in the United States, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company was formed by the merger of Dow Chemical and E. I. du Pont de Nemours and Company on August 31, 2017. It operates through the following segments: Electronics & Imaging; Nutrition & Biosciences; Transportation & Industrial; Safety & Construction, and Non-Core.

Read More on DD:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More